CareCam: Advancing Digital Wound Care with AI

Wound care is a cornerstone of post-surgical recovery and chronic disease management—but it’s also a system under strain due to the numerous in-person assessments. CareCam, a Singapore-based healthtech SME, set out to change that with an AI-powered mobile platform that could remotely assess and monitor wounds in real time, supporting better healing outcomes and reducing the need for clinic-based follow-ups.

Through A*STAR’s T-Up programme, the company brought in a scientist from the A*STAR Institute for Infocomm Research (A*STAR I²R) — a collaboration that fast-tracked their product development and deepened the AI core of their platform.

Jump to Section: The Challenge | Our Innovation | The Impact

Chronic wounds, especially among patients with diabetes or post-surgical complications, demand frequent and accurate monitoring. But access to wound care specialists can be limited, especially in ageing populations or home-based settings.

CareCam envisioned a mobile solution that could allow healthcare professionals to remotely:

• Capture images of a patient’s wound via smartphone
• Assess wound healing using AI-driven analysis
• Track progress without requiring frequent hospital visits

To achieve this, they needed to embed reliable AI models into the mobile app — capable of analysing skin features, detecting inflammation, and tracking healing stages under varied lighting and camera conditions.

With the support of T-Up, Ramanpreet Singh Pahwa, an expert on machine learning from I²R joined CareCam to improve their flagship product - the 3DGait

• Develop and train AI models to utilise 3D AI technology to accurately assess wound severity and healing progress
• Integrate these models into the CareCam mobile platform, ensuring real-time processing

The collaboration helped CareCam achieve milestones that would have otherwise taken years. 3Dgait is currently:

• Piloted in Singapore hospitals Tan Tock Seng Hospital and National Heart Centre.
• Launched in US with facilitation from A*STAR, they have currently garnered interest from major US-based hospitals and are looking at expansion in the US market.
• Looking at further projects with A*STAR Diagnostic Development Hub (A*STAR DxD Hub)

The access to deep tech expertise and the willingness of A*STAR’s scientists to collaborate and see through the success of the product makes the T-Up programme unique. It enables startups to put out products that secondees can also be proud of.

- Dr Elson Yong, CEO of Carecam

By embedding A*STAR’s AI capabilities into its core platform, CareCam is helping reshape how healthcare is delivered — making care more accessible, efficient, and patient-centric. In a healthcare system where capacity, cost, and convenience matter, this public-private partnership is proving that smarter tools can lead to better healing.